This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stryker Announces Chief Accounting Officer Retirement and Successor

Tipranks - Tipranks - Thu May 21, 5:00PM CDT

Meet Samuel – Your Personal Investing Prophet

Stryker ( (SYK) ) just unveiled an update.

Stryker announced on May 20, 2026 that Vice President and Chief Accounting Officer William E. Berry, Jr. will retire from his role effective September 1, 2026, and will serve as Advisor to the Chief Financial Officer until August 15, 2027 under a transition agreement that maintains his current salary and 2026 bonus eligibility but ends his participation in incentive programs after that year. The company named current Vice President and Corporate Controller Emily Baculik as his successor as chief accounting officer effective September 1, 2026, aligning her compensation with the expanded responsibilities through a higher base salary, adjusted bonus target and a planned long-term incentive award, underscoring a structured leadership transition in its finance function.

Berry’s transition agreement provides continuity in Stryker’s financial oversight while avoiding new equity grants, suggesting a controlled wind-down of his role that minimizes disruption for investors and regulators. Baculik’s promotion, supported by more than 20 years of finance and accounting experience at major public companies and progressive roles within Stryker, is structured to retain key talent and reinforce the company’s internal bench strength in a critical governance position.

The most recent analyst rating on (SYK) stock is a Hold with a $330.00 price target. To see the full list of analyst forecasts on Stryker stock, see the SYK Stock Forecast page.

Spark’s Take on SYK Stock

According to Spark, TipRanks’ AI Analyst, SYK is a Neutral.

SYK’s score is driven primarily by strong financial performance (scaling revenue, durable margins, and solid cash generation) and a constructive earnings outlook with reaffirmed full-year guidance despite the cyber disruption. These positives are tempered by very weak technicals (sharp downtrend and bearish momentum) and a stretched valuation (P/E 42.22 with only a ~1.17% yield).

To see Spark’s full report on SYK stock, click here.

More about Stryker

Stryker is a global medical technology company that develops and manufactures medical devices and equipment, with a portfolio spanning orthopaedics, spine, and a range of surgical and hospital products. The company focuses on providing advanced solutions to healthcare providers, positioning itself as a major player in the medical device and healthcare technology markets.

Average Trading Volume: 2,282,579

Technical Sentiment Signal: Hold

Current Market Cap: $120.1B

For an in-depth examination of SYK stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).